• MIPS 2020—What’s New With Improvement Activities

    Excerpted from MIPS—What’s New in 2020 for Ophthalmology (EyeNet, January 2020). Also see MIPS 2020: A Primer and Reference, which is being posted online ahead of print.


    More reporting needed for groups. In 2020, practices that report as a group will only score points for an improvement activity if at least 50% of the practice’s clinicians meet the reporting requirements of that activity. They must each do the activity for a 90-day performance period, but they don’t all have to do it during the same 90-day date range. (In 2019, only one of the group’s clinicians needed to perform the activity.) 

    CMS has removed some improvement activities. CMS has removed 15 activities, including five that you could report via the IRIS Registry in 2019:

    • IA_PSPA_5: Annual registration in the Prescription Drug Monitoring Program
    • IA_CC_6: Use of QCDR to promote standard practices, tools, and processes in practice for improvement in care coordination
    • IA_AHE_4: Leveraging a QCDR for use of standard questionnaires
    • IA_PM_10: Use of QCDR data for quality improvement such as comparative analysis reports across patient populations
    • IA_CC_4: TCPI Participation

    CMS makes substantive changes to IA_PSPA_7: Use of QCDR data for ongoing practice assessment and improvements. CMS removed several QCDR-related improvement activities (see above) and incorporated them into IA_PSPA_7.

    More than 60 improvement activities can be reported via the IRIS Registry in 2020. Although several of the 2019 improvement activities are no longer available for reporting via the IRIS Registry, many more have been added. 

    Previous: MIPS 2020—What’s New With Promoting Interoperability

    Next: MIPS 2020—What’s New With Cost

    DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.

    COPYRIGHT© 2020, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology.®

    All of the American Academy of Ophthalmology (AAO)–developed quality measures are copyrighted by the AAO’s H. Dunbar Hoskins Jr., MD, Center for Quality Eye Care (see terms of use).